All coverage
AstraZeneca (AZN)-Oxford Covid-19 Vaccine Prevents Average of 70% of Covid Cases
By Suzi Ring & Naomi Kresge
What we know about AstraZeneca's head-scratching vaccine results. (Published 2020)
By Rebecca Robbins & Carl Zimmer
Moderna designed its coronavirus vaccine in just 2 days
By Andrew Dunn, Aria Bendix & Susie Neilson
Some companies will make big money off their COVID-19 vaccines — but not as much as they could
By Mark Gollom
Doctors say CDC should warn people the side effects from Covid vaccine shots won't be 'a walk in the park'
By Berkeley Lovelace & Berkeley Lovelace Jr.
Comparing COVID Vaccines: Pfizer vs. Moderna vs. AstraZeneca/Oxford
By Alex B. Berezow
In the first distribution push, 6.4 million doses of Pfizer's vaccine will be shipped across the U.S. (Published 2020)
By Rebecca Robbins
Oxford AstraZeneca Covid vaccine: everything we know so far
By Sarah Boseley & Ian Sample